Related Experiment Video
Updated: Oct 6, 2025

09:34
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
9.1K
Engineered Dutasteride-Lipid Based Nanoparticle (DST-LNP) System Using Oleic and Stearic Acid for Topical Delivery
Norhayati Mohamed Noor1,2, Sana Umar1, Azila Abdul-Aziz2,3
1Department of Pharmaceutics, UCL School of Pharmacy, University College London, London WC1N 1AX, UK.
Bioengineering (Basel, Switzerland)
|January 20, 2022
Summary
This study developed an alcohol-free, lipid-based nanoparticle formulation for topical dutasteride delivery to treat male pattern baldness (MPB). The formulation with oleic acid showed reduced skin permeation, suggesting potential for safer dermal delivery of anti-androgenic drugs.
Area of Science:
- Pharmaceutical Sciences
- Dermatology
- Nanotechnology
Background:
- Male pattern baldness (MPB) significantly impacts men's psycho-social well-being.
- Existing alcohol-based topical treatments can cause adverse reactions.
- There is a need for novel, alcohol-free formulations for MPB treatment.
Purpose of the Study:
- To engineer an alcohol-free lipid-based nanoparticle (LNP) formulation for topical dutasteride (DST) delivery.
- To evaluate the role of oleic acid in the DST-loaded LNP system.
- To assess the suitability of the formulation for dermal delivery of anti-androgenic molecules.
Main Methods:
- DST-loaded LNPs were prepared using emulsification-ultrasonication.
- Two formulations were created: one with oleic acid (Formulation A) and one without (Formulation B).
- Characterization included size, shape, entrapment efficiency, X-ray diffractometry, drug release, and skin permeation studies.
Main Results:
- All formulations were spherical, in the nanometric size range (150-300 nm), with >75% entrapment efficiency.
- Dutasteride was found in an amorphous state within the LNP matrices.
- Formulation A (with oleic acid) exhibited significantly lower dutasteride permeation into the dermis compared to Formulation B.
Conclusions:
- The developed alcohol-free LNP formulation is suitable for topical dutasteride delivery.
- Oleic acid may play a role in modulating drug permeation, potentially enhancing safety.
- The novel formulation shows promise for the dermal delivery of anti-androgenic compounds for MPB treatment.

